Binge eating disorder Eating disorder
Conditions
Interventions
GSH CBT-E is a guided self-help version of CBT-E based on the self help-book
*Overcoming Binge Eating*. Treatment period is 12 weeks. Once a week there will
be a therapy session of 20 minutes. All s
Sponsors
Arkin (Amsterdam)
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Binge Eating Disorder or Other Specified Eating Disorder (OSFED), most similar to Binge Eating disorder diagnosis 2. Age >= 18 3. 19.5
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Acute psychosis 2. Acute depression 3. Suicidal ideation 4. Self induced vomiting as compensatory behavior 5. Receivement of treatment for ED during the past months 6. Pregnancy 7. Expected absence during treatment period 8. Bariatric surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is to compare the efficacy of GSH CBT-E on the amount of binge free days pre- and post-treatment. Primary parameter will be measured through the Eating Disorder Examination (EDE) and Eating Disorder Examination Questionnaire (EDE-Q). All questionnaires will be assessed at start and end of treatment. In week 5, 24 and 36 the EDE-Q will also be conducted. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameter is eating disorder pathology pre and post treatment. Tertiary parameter are cost effectiveness of GSH CBT-E, quality life and clinical impairment. Secondary parameter will be measured through the Eating Disorder Examination (EDE) and Eating Disorder Examination Questionnaire (EDE-Q). Secondary parameters will also be measured 4 weeks after start of treatment and at 3 and 6 months follow up through the EDE-Q. Tertiary parameters will be measured through the questionnaire on Costs associated with Psychiatric illness (TiC-P), the Quality of life questionnaire (EQ-5D-5L), the Clinical Impairment Assessment (CIA) and Working Alliance Inventory (WAI). All questionnaires will be assessed at start and end of treatment. In week 5 the EDE-Q and CIA will be conducted. During week 24 and 36 only the EDE-Q, EQ-5D-5L, TiC-P, and CIA will be conducted. Followed module will serve as a moderator. | — |
Countries
Netherlands
Outcome results
None listed